Aerovate Therapeutics, Inc. (AVTE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.94B |
| Enterprise Value | 2.85B |
| P/E Ratio | -6.66 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.79 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -4.48 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.41 |
| Return On Equity | -0.51 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -113.54M |
| Net Income | -127.41M |
| Diluted EPS | -3,193.3 |
| Total Cash | 55.09M |
| Total Cash/Share | 5.39 |
| Total Debt | 679,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 14.29 |
| Book Value Per Share | 5.13 |
| 52-Week Change | -99.52 |
| 52-Week High | 884.98 |
| 52-Week Low | 2.63 |
| Moving Average 50 Days | 88.74 |
| Moving Average 200 Days | 82.18 |
| Average Volume | 7,993 |
| Shares Outstanding | 28.99M |
| % Held by Institutions | 3.12 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:35 |
| Last Split Date | April 29, 2025 |